Androgen suppression for the treatment of prostate cancer in the elderly

Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
Pierre Mongiat-ArtusMembres du CCAFU

Abstract

Prostate cancer (PaC) is a significant health problem. Elderly have the highest incidence of the disease as age is its strongest risk factor. Despite its complications, the use of androgen suppression in aging patients with prostate cancer has become extremely frequent with probable excess. However, some of these complications carry specific mortality and all of them have a negative impact on quality of life. It is critical to perform a geriatric assessment, concerning physical, mental and social items, before to consider androgen suppression in this population. Indications of androgen suppression for the treatment of prostate cancer follow the guidelines of CCAFU. Delayed treatment deserves a special attention when possible. Treatment modalities are no specific to the elderly, but complications have to be anticipated with preventive measures. Intermittent androgen suppression should be considered with caution. Close follow up will focus on the diagnosis of adverse effects of androgen suppression.

References

May 11, 1999·JAMA : the Journal of the American Medical Association·C R PoundP C Walsh
Jan 12, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John T WeiMartin G Sanda
Mar 21, 2002·Journal of the National Cancer Institute·Arnold L PotoskyJanet L Stanford
Sep 23, 2003·Journal of Molecular Neuroscience : MN·Barbara B Sherwin
Apr 22, 2004·Lancet Neurology·Kristine Yaffe
Jan 14, 2005·The New England Journal of Medicine·Vahakn B ShahinianJames S Goodwin
Jul 15, 2005·JAMA : the Journal of the American Medical Association·Nima SharifiWilliam L Dahut
Sep 29, 2005·The Journal of Clinical Endocrinology and Metabolism·Susan L GreenspanNeil M Resnick
Jan 26, 2006·The Journal of Clinical Endocrinology and Metabolism·Matthew R SmithDavid M Nathan
Mar 1, 2006·Archives of Internal Medicine·Vahakn B ShahinianJames S Goodwin
Sep 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy L KeatingMatthew R Smith
Dec 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vahakn B ShahinianJames S Goodwin
Jul 10, 2008·JAMA : the Journal of the American Medical Association·Grace L Lu-YaoSiu-Long Yao

❮ Previous
Next ❯

Citations

Sep 29, 2011·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·A MitachA Gelet
Apr 28, 2009·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·E XylinasM Rouprêt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
L SalomonLes membres du CCAFU
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
J-J PatardLes membres du CCAFU
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
X DurandLes membres du CCAFU
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
Marc ColombelCarine Rousseau
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
Y NeuzilletMembres du Comité de cancérologie de l’Association française d’urologie
© 2021 Meta ULC. All rights reserved